Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Change in Cash (2016 - 2025)

Veracyte's Change in Cash history spans 14 years, with the latest figure at $47.0 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 236.04% year-over-year to $47.0 million; the TTM value through Dec 2025 reached $122.9 million, up 427.34%, while the annual FY2025 figure was $122.9 million, 427.34% up from the prior year.
  • Change in Cash for Q4 2025 was $47.0 million at Veracyte, down from $95.4 million in the prior quarter.
  • Across five years, Change in Cash topped out at $95.4 million in Q3 2025 and bottomed at -$163.6 million in Q3 2021.
  • The 5-year median for Change in Cash is $9.4 million (2021), against an average of $677000.0.
  • The largest annual shift saw Change in Cash soared 353.27% in 2023 before it plummeted 660.44% in 2025.
  • A 5-year view of Change in Cash shows it stood at $7.5 million in 2021, then crashed by 311.82% to -$15.9 million in 2022, then soared by 188.23% to $14.0 million in 2023, then plummeted by 346.85% to -$34.6 million in 2024, then soared by 236.04% to $47.0 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Change in Cash are $47.0 million (Q4 2025), $95.4 million (Q3 2025), and $33.4 million (Q2 2025).